Immune activation of Bio-Germanium in a randomized, double-blind, placebo-controlled clinical trial with 130 human subjects: Therapeutic opportunities from new insights

[NCT03677921]; www.clinicaltrials.gov [KCT0002726]; https://cris.nih.go.kr.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2020-10, Vol.15 (10), p.e0240358-e0240358
Hauptverfasser:	Cho, Jung Min, Chae, Jisuk, Jeong, Sa Rang, Moon, Min Jung, Shin, Dong Yeob, Lee, Jong Ho
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Anticancer properties Antiviral drugs Arthritis Biochemical analysis Biology and life sciences Biomedical materials Biosynthesis Cancer therapies Cancer treatment Care and treatment Chemical compounds Chemotherapy Clinical trials Cytokines Cytotoxicity Dietary supplements Double-Blind Method Double-blind studies Evaluation Fatalities Female Fermentation Food Germanium Germanium - administration & dosage Germanium - immunology Germanium compounds Healthy Volunteers Human subjects Humans Immunoglobulin G Immunoglobulin G - metabolism Immunostimulants Immunostimulation Immunotherapy Inflammation Killer Cells, Natural - metabolism Laboratories Leukocyte Count Leukocytes Lymphocytes B Male Medicine and health sciences Microorganisms Middle Aged Natural killer cells Neutrophils Nutrition Organogermanium compounds Osteoporosis Pharmacology Physical Sciences Quality of Life Research Design Senile Supplementation Supplements Testing Toxicity Treatment Outcome Tumor Necrosis Factor-alpha - metabolism Tumor necrosis factor-TNF Tumor necrosis factor-α Urinalysis Yeasts Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	[NCT03677921]; www.clinicaltrials.gov [KCT0002726]; https://cris.nih.go.kr.
ISSN:	1932-6203 1932-6203
DOI:	10.1371/journal.pone.0240358